Eagle Pharmaceuticals Pty., OncoGenex Technologies deal

Eagle received exclusive, worldwide rights to OncoGenex’s Tocosol paclitaxel. OncoGenex is eligible for undisclosed royalties and a portion of any sublicensing payments received by Eagle. OncoGenex ga...